ArticleTherapeutics and clinical risk management2008

Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis.

Piet Geusens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.